Poseida Therapeutics (PSTX) Short Interest Ratio & Short Volume → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free PSTX Stock Alerts $2.86 -0.11 (-3.70%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Poseida Therapeutics Short Interest DataCurrent Short Interest5,030,000 sharesPrevious Short Interest6,040,000 sharesChange Vs. Previous Month-16.72%Dollar Volume Sold Short$17.40 millionShort Interest Ratio7.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares96,960,000 sharesPercentage of Shares Shorted5.19%Today's Trading Volume367,120 sharesAverage Trading Volume684,587 sharesToday's Volume Vs. Average54% Short Selling Poseida Therapeutics ? Sign up to receive the latest short interest report for Poseida Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPSTX Short Interest Over TimePSTX Days to Cover Over TimePSTX Percentage of Float Shorted Over Time Ad True Market Insiders4 Cryptos BETTER than BitcoinFormer Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Poseida Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20245,030,000 shares $17.40 million -16.7%N/A7.2 $3.46 4/30/20246,040,000 shares $14.62 million +49.1%9.7%8.5 $2.42 4/15/20244,050,000 shares $9.84 million -1.7%6.6%5.4 $2.43 3/31/20244,120,000 shares $13.14 million +7.3%6.7%5.7 $3.19 3/15/20243,840,000 shares $12.36 million +11.3%6.2%5.3 $3.22 2/29/20243,450,000 shares $13.66 million -6.0%5.6%3.4 $3.96 Get the Latest News and Ratings for PSTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Poseida Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,670,000 shares $13.58 million +1.4%6.0%3.9 $3.70 1/31/20243,620,000 shares $12.45 million +22.7%5.9%3.9 $3.44 1/15/20242,950,000 shares $9.00 million +1.4%4.8%3.4 $3.05 12/31/20232,910,000 shares $9.78 million -10.5%4.7%3.5 $3.36 12/15/20233,250,000 shares $10.53 million +10.2%5.3%3.8 $3.24 11/30/20232,950,000 shares $7.88 million -17.8%5.0%3.8 $2.67 11/15/20233,590,000 shares $7.93 million +18.5%6.1%7.4 $2.21 10/31/20233,030,000 shares $6.12 million -22.1%5.7%5.7 $2.02 10/15/20233,890,000 shares $9.10 million -0.5%7.3%4.9 $2.34 9/30/20233,910,000 shares $9.31 million +15.0%7.4%4.9 $2.38 9/15/20233,400,000 shares $6.94 million -6.1%6.4%3.6 $2.04 8/31/20233,620,000 shares $7.57 million -4.5%6.8%3.1 $2.09 8/15/20233,790,000 shares $9.63 million -5.5%7.1%3.3 $2.54 7/31/20234,010,000 shares $6.94 million -2.9%6.5%3.6 $1.73 7/15/20234,130,000 shares $7.85 million -6.6%6.7%4.7 $1.90 6/30/20234,420,000 shares $7.78 million +5.0%8.1%4.7 $1.76 6/15/20234,210,000 shares $10.40 million -10.2%7.7%5 $2.47 5/31/20234,690,000 shares $10.65 million +3.3%8.5%7 $2.27 5/15/20234,540,000 shares $13.39 million +3.2%8.3%6.1 $2.95 4/30/20234,400,000 shares $11.62 million +4.0%8.0%5.9 $2.64 4/15/20234,230,000 shares $9.52 million +19.5%7.7%5.8 $2.25 3/31/20233,540,000 shares $10.90 million +2.0%6.4%5.5 $3.08 3/15/20233,470,000 shares $14.44 million +18.4%6.3%5.6 $4.16 2/28/20232,930,000 shares $16.67 million +10.2%5.4%4.9 $5.69 2/15/20232,660,000 shares $18.83 million -14.7%4.8%4.8 $7.08 1/31/20233,120,000 shares $21.72 million -0.3%5.7%5.9 $6.96 1/15/20233,130,000 shares $22.04 million +13.8%5.7%6.6 $7.04 12/30/20222,750,000 shares $14.58 million +10.4%5.0%6.1 $5.30 12/15/20222,490,000 shares $15.49 million +19.1%4.5%5.8 $6.22 11/30/20222,090,000 shares $9.53 million -4.6%3.8%5.2 $4.56 11/15/20222,190,000 shares $10.53 million +10.1%4.0%6.3 $4.81 10/31/20221,990,000 shares $8.16 million +2.1%3.6%5.5 $4.10 10/15/20221,950,000 shares $8.39 million +4.8%3.5%1.3 $4.30 9/30/20221,860,000 shares $6.57 million +20.8%3.4%1.3 $3.53Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… 9/15/20221,540,000 shares $5.61 million +5.5%2.8%1.1 $3.64 8/31/20221,460,000 shares $4.83 million -0.7%3.3%1 $3.31 8/15/20221,470,000 shares $6.32 million -25.4%3.1%1.1 $4.30 7/31/20221,970,000 shares $4.91 million +9.4%5.4%1.5 $2.49 7/15/20221,800,000 shares $4.91 million +3.5%4.9%7.5 $2.73 6/30/20221,740,000 shares $4.49 million -10.3%4.8%7.2 $2.58 6/15/20221,940,000 shares $4.23 million -0.5%5.3%8.2 $2.18 5/31/20221,950,000 shares $4.43 million +2.1%5.3%10.9 $2.27 5/15/20221,910,000 shares $4.16 million +24.0%5.2%10.6 $2.18 4/30/20221,540,000 shares $4.76 million +16.7%4.2%8.8 $3.09 4/15/20221,320,000 shares $5.37 million -2.2%3.6%9.2 $4.07 3/31/20221,350,000 shares $6.05 million -0.7%3.7%8.7 $4.48 3/15/20221,360,000 shares $5.18 million +14.3%3.7%8.6 $3.81 2/28/20221,190,000 shares $4.34 million +2.6%3.3%7.3 $3.65 2/15/20221,160,000 shares $4.66 million -7.2%4.2%7.2 $4.02 1/31/20221,250,000 shares $5.94 million +48.4%3.6%7.7 $4.75 1/15/2022842,100 shares $4.43 million +28.7%2.4%5.3 $5.26 12/31/2021654,200 shares $4.46 million -2.7%N/A0 $6.81 12/15/2021672,300 shares $4.56 million +26.5%1.9%3.5 $6.79 11/30/2021531,400 shares $3.69 million +1.4%1.5%2.6 $6.95 11/15/2021524,200 shares $3.82 million -26.6%1.5%2.4 $7.29 10/29/2021714,100 shares $4.58 million +7.2%2.0%3.3 $6.41 10/15/2021666,100 shares $4.37 million -53.4%1.9%3.3 $6.56 9/30/20211,430,000 shares $10.42 million +4.4%4.1%8.8 $7.29 9/15/20211,370,000 shares $11.30 million -18.5%3.9%7.3 $8.25 8/31/20211,680,000 shares $14.52 million -1.8%4.8%8.6 $8.64 8/13/20211,710,000 shares $15.05 million +1.8%4.9%9.4 $8.80 7/30/20211,680,000 shares $13.62 million -42.5%4.8%9.3 $8.11 7/15/20212,920,000 shares $24.97 million +3.6%8.4%15.8 $8.55 6/30/20212,820,000 shares $28.26 million -6.9%8.1%15.2 $10.02 6/15/20213,030,000 shares $28.24 million -5.6%8.7%17.5 $9.32 5/28/20213,210,000 shares $27.12 million No Change9.3%13.5 $8.45 5/14/20213,210,000 shares $26.68 million +1.9%9.3%10.2 $8.31 4/30/20213,150,000 shares $30.27 million +1.6%9.4%8.6 $9.61 4/15/20213,100,000 shares $28.18 million -17.8%9.2%8 $9.09 3/31/20213,770,000 shares $33.40 million +16.0%11.3%8.9 $8.86 3/15/20213,250,000 shares $36.34 million +9.8%9.8%7 $11.18 2/26/20212,960,000 shares $35.25 million +28.1%8.9%8.2 $11.91 2/12/20212,310,000 shares $21.88 million +23.5%7.0%7.7 $9.47 1/29/20211,870,000 shares $16.53 million +14.7%7.8%8.3 $8.84 1/15/20211,630,000 shares $14.07 million No Change6.8%8.3 $8.63 PSTX Short Interest - Frequently Asked Questions What is Poseida Therapeutics' current short interest? Short interest is the volume of Poseida Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 5,030,000 shares of PSTX short. Learn More on Poseida Therapeutics' current short interest. What is a good short interest ratio for Poseida Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PSTX shares currently have a short interest ratio of 7.0. Learn More on Poseida Therapeutics's short interest ratio. Is Poseida Therapeutics' short interest increasing or decreasing? Poseida Therapeutics saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 5,030,000 shares, a decrease of 16.7% from the previous total of 6,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Poseida Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Poseida Therapeutics: Black Diamond Therapeutics, Inc. (3.80%), Caribou Biosciences, Inc. (13.13%), SOPHiA GENETICS SA (0.05%), Adaptimmune Therapeutics plc (1.39%), Invivyd, Inc. (9.17%), Tenaya Therapeutics, Inc. (5.13%), Coherus BioSciences, Inc. (18.98%), Zura Bio Limited (3.81%), Innate Pharma S.A. (0.09%), Replimune Group, Inc. (19.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Poseida Therapeutics stock? Short selling PSTX is an investing strategy that aims to generate trading profit from Poseida Therapeutics as its price is falling. PSTX shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Poseida Therapeutics? A short squeeze for Poseida Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PSTX, which in turn drives the price of the stock up even further. How often is Poseida Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PSTX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ADAP Short Interest ATHA Short Interest DTIL Short Interest PASG Short Interest ALGS Short Interest AUTL Short Interest IMTX Short Interest MESO Short Interest RLAY Short Interest HUMA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PSTX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poseida Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.